prof. MUDr. Jiří Mayer, CSc.
Department head, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 3643, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 1611
2022
-
Very rare near-haploid acute lymphoblastic leukemia resistant to immunotherapy and CAR-T therapy in 19-year-old male patient
CLINICAL CASE REPORTS, year: 2022, volume: 10, edition: 3, DOI
2021
-
Acute myeloid leukemia regression induced by palbociclib and ponatinib in patient –derived xenograft model.
Year: 2021, type: Conference abstract
-
Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1(T315I)-compound mutations
AMERICAN JOURNAL OF CANCER RESEARCH, year: 2021, volume: 11, edition: 9
-
Cévní nežádoucí účinky u pacientů s chronickou myeloidní leukemií při terapii inhibitory tyrozinkináz v každodenní klinické praxi – analýza z databáze INFINITY
Year: 2021, type: Conference abstract
-
CLLEAR – Czech national registry of CLL patients: complete data analysis 2021.
Year: 2021, type: Conference abstract
-
CLLEAR – Český registr pacientů s chronickou lymfocytární leukemií: analýza dat 2021.
Year: 2021, type: Conference abstract
-
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
JOURNAL OF HEMATOLOGY & ONCOLOGY, year: 2021, volume: 14, edition: 1, DOI
-
COVID-19's natural course among ambulatory monitored outpatients
Nature Scientific Reports, year: 2021, volume: 11, edition: 1, DOI
-
CoVigi phase IV multicentric trial evaluating COVID-19 vaccination adverse events and immune response dynamics in cancer patients: First results on antibody and cellular immunity
Year: 2021, type: Conference abstract
-
Current view of neoadjuvant chemotherapy in primarily resectable pancreatic adenocarcinoma
Neoplasma, year: 2021, volume: 68, edition: 1, DOI